Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
60
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
2013
0Primary Completion Date
2016
0Study Completion Date
2016
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Biological0
Intervention Name
MGA2710
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
A Tissue Procurement and Examination Substudy of Study CP-MGA271-01 (NCT01391143)0
Last Updated
February 8, 2022
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
The purpose of this study is to gain a better understanding about how the study drug MGA271 works. No test drug will be given in this study. Patients with easily accessible tumors at the screening visit for participation in Study CP-MGA271-01 will be asked to participate in this substudy. Patients will undergo two excisional biopsies, punch biopsies, or core needle biopsies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
